Earlier this week, the Drug Enforcement Administration (DEA) held a preliminary hearing as part of the ongoing process to determine whether cannabis should be reclassified from Schedule I to Schedule III of the Controlled...more
Earlier this week, the Department of Justice proposed reclassifying cannabis from Schedule I to Schedule III under the Controlled Substances Act. The move follows an August 2023 recommendation from the Department of Health...more
5/6/2024
/ Agribusiness ,
Banks ,
Controlled Substances Act ,
DEA ,
Decriminalization of Marijuana ,
Department of Health and Human Services (HHS) ,
Financial Services Industry ,
FinCEN ,
Food and Drug Administration (FDA) ,
Internal Revenue Code (IRC) ,
Know Your Customers ,
Marijuana ,
Marijuana Related Businesses ,
Medical Marijuana ,
NIDA ,
Popular ,
Schedule I Drugs